You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Spray-based visual indicator of opioids for the rapid and effective decontamination of large areas
SBC: TRITON SYSTEMS, INC. Topic: CBD20AT001Triton Systems, Inc. will collaborate with The University of Massachusetts Lowell to develop a spray-based technology for the rapid, visual identification of opioids, turning contaminated areas from nondescript white powders to a brightly colored spots for easy recognition with the naked eye. The technology leverages molecular recognition units that bind strongly and specifically to a variety of o ...
STTR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense -
Opioid Indicator Spray for Complex Surfaces
SBC: Clear Scientific, LLC Topic: CBD20AT001Opioids, especially synthetic opioids, are a constant threat to the safety of civilian first responders; there are now serious concerns about their use in modern chemical warfare. Fentanyl and its many analogues (carfentanil, remifentanil, lofentanil, mefentanil, sufentanil, etc.) are extremely hazardous—if ingested or inhaled, many synthetic opioids cause lethal intoxication with only a few gra ...
STTR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense -
Energy & Power Dense Supercapacitor: On-Chip Integration in MEMs Fabrication
SBC: MAINSTREAM ENGINEERING CORP Topic: DMEA21A001Due to recent advances in the field of microelectronics, there is an increasing demand for micro-sized energy storage devices that are capable of being incorporated into and provide energy for MEMS devices. In order to continue to enable this technological growth, and the benefits that stem from it, the storage density of electrical energy must also continually be improved, especially with respect ...
STTR Phase I 2021 Department of DefenseDefense Microelectronics Activity -
Development of selective calpain-1 inhibitors for chronic pain
SBC: 1910 GENETICS INC. Topic: 105PROJECT SUMMARY Never in the history of the United States has the unmet medical need to develop novel, non-opioid therapeutics for chronic pain been more urgent than it is today. More than 65 million US adults suffer from chronic pain, resulting in almost $635 billion in annual healthcare costs. Despite their limited efficacy, and potential for addiction, tolerance, and impaired motor performance, ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Computer-aided design for improved lantibiotics
SBC: Oragenics, Inc. Topic: 400ABSRACT With the ever-increasing problem of antibiotic resistance and the concurrent use of antibiotics in the food chain and in agriculture, there is an urgent and unmet need for new classes of antibiotics. Lantibiotics represent a large untapped pipeline of attractive scaffolds for the development of novel antibiotics. Previous in vitro and in vivo studies support the concept that lantibiotics a ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
VAL-0914 Decreases PAO to Protect Against Cardiac Proteinopathies
SBC: Enable Therapeutics LLC Topic: NHLBIPROJECT SUMMARY Soluble pre-amyloid oligomers (PAO) are the most potent mediators of cytotoxicity, despite common focus on autophagy as a means to clear larger misfolded protein aggregates. Specifically, PAO, rather than aggresomes, are most correlated with desmin-related cardiomyopathy (DRC) caused by an Arg120Gly missense mutation of αB-Crystallin (CryABR120G). In addition to causing DRC, emerg ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
A Peptide-Based Polyplex Platform for Nucleotides Delivery to the Sites of Inflammation
SBC: Trasir Therapeutics, Inc. Topic: 100AbstractRNA interference (RNAi) is an evolutionary conserved mechanism for post transcriptional control of protein expression in which short double-stranded RNA target specific messenger RNA (mRNA) for degradation, thus inhibiting protein translation. siRNA has great potential to revolutionize medicine by enabling highly specific and efficient silencing of proteins involved in disease pathogenesis ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
A MEMS-Based High-Throughput Photostimulation Device with Commercial Backplane Integration
SBC: BOULDER NONLINEAR SYSTEMS, INC. Topic: NIMHBoulder Nonlinear Systems (BNS) and Prof. Rikky Muller at UC-Berkeley propose a two-phase effort to address current speed limitations in holographic photostimulation. Specifically, the proposed innovations aim to achieve streaming of high-resolution holograms at up to 10,000 frames per second (fps) to enable closed-loop optogenetic control.Optical imaging and photostimulation have emerged as compl ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Development of a biomarker panel for screening and early detection of gynecological cancers
SBC: MDDx, Inc. Topic: 102PROJECT SUMMARY It is estimated that more than 80,000 women will be diagnosed with ovarian (OvCA) and endometrial (EndoCA) cancers this year in the U.S. and this will result in the death of 26,000 women. There are no screening tests for either of these two female-specific cancers which also disproportionally affect ethnically distinct populations. For both cancers, detection of early stage, locali ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Biomimetic size-adaptable heart valve for prosthesis-patient mismatch
SBC: Autus Valve Technologies, Inc. Topic: NHLBIABSTRACT The overall goal of this Phase I STTR project is to develop a biomimetic size-adjustable prosthetic heart valve (Autus Size-Adaptable Valve) that can be expanded post-implantation to accommodate changes in blood flow due to somatic growth or cardiac remodelling, to prevent the complications of valve prosthesis-patient mismatch (PPM). By design, all existing surgical prosthetic valves have ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health